Purpose: The aim of the present study was to compare microvessel density (MVD) between CGCGs and PGCGs of the oral cavity using CD31 and CD34.
Introduction
Intra-and extra-osseous lesions occur within the head and neck region, some of which are known counterparts like central and peripheral ameloblastomas and ghost cell odontogenic tumors. [1] However, this relationship is not so clear for giant cell lesions and it is still debatable whether these are separate entities or variants of a single lesion, which can be found at different locations. [2] [3] Peripheral giant cell granulomas (PGCGs) develop in response to local irritation or trauma, occasionally erode the underlying bone, and have a low recurrence rate, especially after adequate treatment. On the other hand, the etiology of central giant cell granulomas (CGCG) is controversial and they are known to demonstrate diverse clinical features and behavior. Some cases demonstrate an indolent behavior and minimal symptoms, while others develop in a younger age group, behave aggressively and tend to recur. Despite their clinical differences, these intra-and extra-osseous lesions have similar histologic characteristics .They are comprised of variable amounts of multinucleated giant cells in a background of the oval to spindle-shaped mononuclear cells. [3] This contradiction has been a major concern among researchers leading to studies on various cytomorphometric, immunohistochemical, and ultrastructural aspects of these lesions. [2, [4] [5] [6] Angiogenesis is an important factor that occurs in both physiological and pathological conditions and it has been shown that angiogenesis would affect the biologic behavior of various neoplastic and non-neoplastic diseases. This phenomenon is evaluated through assessment of MVD using various endothelial cell markers [7] such as CD34 and CD31. CD34 is a 110-kDa cell surface glycoprotein and functions as a cell-cell adhesion factor. It may also mediate the attachment of stem cells to the bone marrow extracellular matrix or directly to stromal cells. Cells expressing CD34 (CD34+ cell) are normally found in the bone marrow as hematopoietic cells, or in mesenchymal stem cells, endothelial progenitor cells, endothelial cells of blood vessel. [7] [8] CD31 is a 130-kDa glycoprotein that appears on blood endothelial cells, platelets, macrophages and lymphocytes (T cells, B cells, and NK cells) and osteoclast by immunohistochemistry technique, CD31 is used to demonstrate the presence of endothelial cells in histological tissue sections that helping to evaluate the degree of tumor angiogenesis. [7] Vascular endothelial growth factor (VEGF) has been previously investigated in giant cell lesions and has been suggested that those situated in the jawbones, particularly, lie within the range of primary proliferative vascular lesions. [4] However, this notion was not supported by Kahn et al. [9] Antigenic factors like VEGF and basic fibroblast growth factor (bFGF) have been reported to have a closer relationship with osteoclast genesis than angiogenesis. [4, 9] Microvessel density (MVD) and microvessel count using endothelial cell markers have been evaluated and compared between CGCG and PGCG with contradictory results. [4, [10] [11] [12] [13] Considering the importance of this process and the fact that endothelial cells not only function in angiogenesis-related activities but also have a role in various phenomena, we aimed to evaluate angiogenesis in PGCG and CGCG using CD34 and CD31. We were not able to find previous research in this field using the latter pan-endothelial protein. Primary antibodies were omitted for both groups as negative controls. [14] In order to determine MVD, all stained sections were screened at 40× by two observers using a doubleheaded microscope and vascular hotspots (areas containing the highest amount of vascularization) were identified. Of these, five were selected for counting mi- between the observers were resolved by consensus.
Materials and Method
Statistical analysis was performed using t-test and p<0.05 was considered significant.
Results
According to the inclusion and exclusion criteria, our study sample consisted of 18 PGCGs of which 6 and 12 occurred in males and females, respectively (p= 0.23).
Of these, 10 were found in the mandible and 8 in the were significantly different between the two age groups (p< 0.05) in CGCG, while CD31 showed statistically significant difference in lesion size (p< 0.01) in PGCGs.
Discussion
In the present study, we evaluated the angiogenesis via assessment of MVD using endothelial cell markers CD34 and CD31. Analysis of our demographic data showed both lesions to be more common in women as compared to men and more prevalent in the mandible compared to the maxilla, which was in agreement with previous reports. [3, [11] [12] The age range of the patients fell within those described formerly; however, the mean age was somewhat higher in the current investigation in comparison to some studies. [3, [13] [14] [15] [16] Histopathologically, similar to other studies, [4, 13] we observed well-formed large vessels in the pe- A higher amount of antigenic cytokines like VEGF, TGFβ1, TGFα, TNFα, PDGF and thymidine phosphorylate in CGCGs, leads to increased endothelial cell proliferation and angiogenesis, [2] which supports our results. Hallikeri et al. [14] also observed a significantly higher MVD in CGCGs, similar to the findings of the current investigation. Likewise, Tobón-Arroyave et al. [15] reported microvessel counts to be larger in aggressive CGCGs compared to peripheral lesions. Interestingly, microvessel count was similar in PGCGs and non-aggressive CGCGs, but lower in PGCG compared to aggressive CGCG. On the other hand, the results obtained in the current investigation are in contrast to those who have found increased angiogenesis in PGCG compared to CGCG. [4, 11] This could be attributed to differences in the antibody used for assessment of MVD, its clone, or the methodology of measurement.
According to our results, both markers showed significantly higher vasculature in women with PGCG compared to men within the same lesion. By evaluating estrogen and progesterone receptor proteins, Whitaker et al. [16] suggested PGCGs to be under hormonal influence, which can help explain this finding.
CD34 and CD31 are panendothelial markers that are known to stain both old-and newly-formed vessels.
In contrast, CD105 strongly reacts with newly formed vasculature in angiogenic tissues but weakly or not at all with endothelial cells of normal tissues. [17] [18] The difference in CD105 between CGCG and PGCG was reported to be non-significant, [17] [2] have been shown to differ between these lesions and according to our findings, MVD assessed by panendothelial markers could be added to these factors.
Conclusion
Based on our findings, it seems that combination of old and newly formed vessels are different in PGCGs compared to CGCGs, which could be possibly responsible for the variation in their biologic behavior.
